High prevalence of behçet's disease in southern italy

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.77, 2013, Pages

  Olivieri, Ignazio ^a   Leccese, Pietro ^a   Padula, Angela ^a   Nigro, Angelo ^a   Palazzi, Carlo ^a   Gilio, Michele ^a   D'Angelo, Salvatore ^a,b  

^a Madonna delle Grazie Hospital of Matera   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

Beh et's disease; Epidemiology; Italy; Population based study

Indexed keywords

ADULT; ARTICLE; BEHCET DISEASE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; ITALY; MALE; PATIENT IDENTIFICATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADULT; BEHCET SYNDROME; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; URBAN HEALTH; YOUNG ADULT;

EID: 84884924244     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANFORD MR: Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 213-20.
2. CHAMBERLAIN MA: Behçet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 1977; 36: 491-9.
3. YURDAKUL S, GUNAYDIN I, TUZUN Y et al.: The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15: 820-2.
4. JANKOWSKI J, CROMBIE I, JANKOWSKI R: Behçet's syndrome in Scotland. Postgrad Med J 1992; 68: 566-70.
5. EK L, HEDFORS E: Behçet's disease: a review and report of 12 cases from Sweden. Acta Derm Venereol 1993; 73: 251-4.
6. Al-DALAAN AN, al BALAA SR, el RAMAHI K, et al.: Behçet's disease in Saudi Arabia. J Rheumatol 1994; 21: 658-61.
7. ZOUBOULIS CC, KOTTER I, DJAWARI D, et al.: Epidemiological features of Adamantiades- Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
8. SALVARANI C, PIPITONE N, CATANOSO MG, et al.: Epidemiology and clinical course of Behçet's disease in the Reggio Emilia Area of Northern Italy: a seventeen-year population- based study. Arthritis Rheum 2007; 57: 171-8.
9. MAHR A, BELARBI L, WECHSLER B, et al.: Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58: 3951-9.
10. CALAMIA KT, WILSON FC, ICEN M, CROWSON CS, GABRIEL SE, KREMERS HM: Epidemiology and clinical characteristics of Behçet's disease in the US: a populationbased study. Arthritis Rheum 2009; 61: 600- 4.
11. GüL A, HAJEER AH, WORTHINGTON J, BARRETT JH, OLLIER WE, SILMAN AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44: 239-40.
12. SALVARANI C, BOIARDI L, MANTOVANI V, et al.: Association of MICA alleles and HLAB51 in Italian patients with Behçet's disease. J Rheumatol 2001; 28: 1867-70.
13. D'ANGELO S, LECCESE P, SANTOSPIRITO EV, et al.: High frequency of HLA B*5101 and B*5108 in Italian patients with Behçet's disease [abstract]. Clin Exp Rheumatol 2010; 28 (Suppl. 60): S168.
14. International study group for Behçet's disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
15. PIPITONE N, BOIARDI L, OLIVIERI I, et al.: Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 2004; 22 (Suppl. 36): S46-51.
16. De MENTHON M, LAVALLEY MP, MALDINI C, GUILLEVIN L, MAHR A: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61: 1287-96.
17. ALBRECHT J, ATZENI F, BALDINI C, et al.: Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 2006; 24 (Suppl. 40): S52-9.
18. HANDA T, TSUNEKAWA H, YONEDA M, et al.: Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab. Clin Exp Rheumatol 2011; 29 (Suppl. 67): S58-63.
19. OLIVIERI I, LECCESE P, D'ANGELO S, et al.: Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. Clin Exp Rheumatol 2011; 29 (Suppl. 67): S54-7.